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Abstract 
Protein phosphatase 6 regulatory subunit 3 
(PPP6R3) is a regulatory subunit of the PP6 
holoenzyme complex involved in the turnover of 
serine and threonine phosphorylation events during 
mitosis. PPP6R3 shows abundant mRNA splicing 
variants and numerous functional protein isoforms. 
PPP6R3 gene is often involved in abnormal 
chromosomal translocations and it is found as a 
fusion gene partner in different kind of cancers. 
Keywords 
PPP6R3, protein phosphatase 6 regulatory subunit 3, 
C11orf23, SAPS, phosphorylation, breast cancer,  
bladder cancer, lung cancer, nodular fasciitis 
Identity 
Other names: Serine/threonine-protein phosphatase 
6 regulatory subunit 3, chromosome 11 open reading 
frame 23 C11orf23, SAPS domain family member 3, 
SAPS3, SAPLa, SAPL, SAP190, sporulation-
induced transcript 4-associated protein, 
DKFZp781E2374, DKFZp781O2362, 
DKFZp781E17107, FLJ11058, FLJ43065, 
KIAA1558, MGC125711, MGC125712 
HGNC (Hugo): PPP6R3 
Location: 11q13.2 
Figure. 1. PPP6R3 gene and splicing variants/isoforms.  The figure shows the locus on chromosome 11 of the PPP6R3 gene 
(reworked from https://www.ncbi.nlm.nih.gov/gene; http://grch37.ensembl.org; www.genecards.org) 










PPP6R3, alias protein phosphatase 6 regulatory 
subunit 3, is a protein coding gene that starts at 
68,460,718 nt and ends at 68,615,334 nt from qter 
(RefSeq NC_000011.10) and with a length of 
154617 bp. It is proximal to LRP5 (LDL receptor  
related protein 5) gene. Around the genomic locus of 
PPP6R3 take place different promoter or enhancer 
transcriptional elements that are located at +0.5 kb, 
+837.9 kb and -359.7 kb. 
Transcription 
Exists a high number of spliced version of PPP6R3 
(Stefansson and Brautigan, 2006) and their main 
















































































































4942 - - - - - - 
Var.43 NR_147967 5401 - - - - - - 
Var.45 NR_147969 5235 - - - - - - 
Var.46 NR_147970 4978 - - - - - - 


















































































































































































































































































































































































































































































513 - - - - - - 






582 - - - - - - 






830 - - - - - - 
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5 (?) 538 - - - - - - 






500 - - - - - - 













































7 (?) 826 - - - - - - 






















5 (?) 687 - - - - - - 










































19 (?) 2968 - - - - - - 
Table.1 Alterative splicing variants and isoforms of PPP6R3.  (reworked from http://grch37.ensembl.org; 
ttps://www.ncbi.nlm.nih.gov; https://web.expasy.org/protparam/; https://www.uniprot.org). ncRNA = non-coding RNA; nonsense 
md = nonsense mediated decay; (?) = undetermined; MW = molecular weight; pI = theoretical pI. 
 
Pseudogene 
Currently, pseudogenes for PPP6R3 have not been 
detected in the human genome. 
Protein 
Description 
PPP6R3 encodes the protein phosphatase 6 
regulatory subunit 3, which belongs to protein 
phosphatase 6 (PP6) complex (York et al., 2014; 
Guergnon et al., 2009) in which there are also 
PPP6R1, PPP6R2 and PPP6C proteins.  
PP6 complex is a member of the PP2A subfamily of 
protein phosphatases and shows a Sit4-associated 
protein domain (SAPS domain) (Stefansson and 
Brautigan, 2006).  
There are evidence about many functioning isoforms 
for PPP6R3 protein (Table.1) that maintain the 
SAPS main domain. 
Expression 
PPP6R3 is ubiquitously expressed in human tissues 
and mRNA levels are highly expressed in heart 
(Ziembik et al., 2017; Stefansson and Brautigan, 
2006) and also in immune cells and lymphoid 
tissues, in particular in T helper cells, cytotoxic T 
cells and monocytes (Ziembik et al., 2017). On the 
contrary, PPP6R3 protein is found at high levels in 
lung, bladder, spleen and pancreas (Ziembik et al., 
2017). 
Localisation 
PPP6R3 localize in various subcellular 
compartments: it is present mainly in the cytoplasm 
but it is also found in Golgi apparatus, nucleoplasm, 
nucleus and associated with the plasma membrane 
(Stefansson et al., 2008; 
https://www.ncbi.nlm.nih.gov). 
Function 
PPP6R3 is a subunit of protein phosphatase 6 (PP6), 
a trimeric holoenzyme of the family of 
phosphoprotein phosphatases (PPPs), involved in the 
turnover of serine and threonine phosphorylation 
events during mitosis so much to be able to regulate 
the cell cycle progression (Stefansson and Brautigan, 
2007). PPP6R3 acts as a regulatory element in the 
PP6 protein complex and could function as a scaffold 
for PP6 subunits. It was observed that a high amount 
of PPP6R3 in cell result in a great destabilization, 
upon depletion, of the catalytic subunit of PP6 
(Rusin et al.,2017). Moreover, PPP6R3 could have 
an important role in maintaining immune self-
tolerance through the control of the nuclear factor 
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kappaB (NF-kB) (Ziembik et al., 2017) and the TNF- 
α/NF-kB pathway (Bouwmeester et al., 2004).  
 
Figure.2 PPP6R3 protein isoforms.  Graphical representation of the PPP6R3 protein isoforms with highlight of the main verified 
post-translational modifications (reworked from http://grch37.ensembl.org; https://www.ncbi.nlm.nih.gov; Stefansson and 
Brautigan, 2006). 
 
Pediatric musculoskeletal development.   
PPP6R3, along with other genes, seems to be 
involved in bone mineralization and myogenensis 
during pediatric development (Medina-Gomez et al., 
2017). However, the inner significance of this 
relation, such as the impact on musculoskeletal 
structure, on strength or weakness and on the 
predisposition to develop the related pathologies, 
needs to be clarified.  
 Interactions with the influenza A virus 
transcription/replication machinery.  
 PPP6R3 is a member of PP6 complex and some 
authors found that PP6 interact directly with two 
subunits, i.e. PB1 and PB2, of the viral RNA-
dependent RNA polymerase (RdRP) of the influenza 
A virus.  
This suggest a role of PP6 complex, and for 
regulatory subunit PPP6R3, in the regulation of 
phosphorylation also in the influenza A virus 
transcription/replication machinery (York et al., 
2014). 
Homology 
PPP6R3 is highly and abundant conserved in many 
species and its homology between the species is 
reported in Table.2 







Human H.sapiens PPP6R3 100 100 
Chimpanzee P.troglodytes LOC710120 99.6 99.8 
Macaco M.mulatta PPP6R3 95.6 96.4 
Wolf C.lupus PPP6R3 92.8 92.2 
Cattle B.taurus PPP6R3 91.8 96.0 
Mouse  M.musculus  Ppp6r3 90.5 96.3 
Rat R.norvegicus  Ppp6r3 90.6 95.5 
Chicken G.gallus PPP6R3 82.8 91.5 










X.tropicalis  Ppp6r3 75.6 80.3 
Zebrafish  D.rerio  Ppp6r3 71.6 79.0 
Table.2 PPP6R3 homology (reworked from 
ps://www.ncbi.nlm.nih.gov/homologene) 
Name 5' end 3' end Loc1 Loc2 Description Type Disease Organ Code Ref. 





Fusion gene Adenocarcinoma Breast BRCA 
Hu et al., 
2018 















Fusion gene Malignant melanoma Skin 
SKC
M 
Hu et al., 
2018 







(?) (?) (?) - 






















et al., 2012 






(?) (?) (?) - 





Fusion gene Adenocarcinoma Breast BRCA 
Yoshihara et 
al., 2015 
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Fusion gene Malignant melanoma Skin 
SKC
M 
Hu et al., 
2018; Klijn 
et al., 2015 





Fusion gene Adenocarcinoma Breast BRCA 
Yoshihara et 
al., 2015 
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Fusion gene Germ cell tumor, NOS Testis TGCT 
Hoff et al., 
2016 





Fusion gene Adenocarcinoma Breast BRCA 
Yoshihara et 
al., 2015 























Liu et al., 
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Fusion gene Adenocarcinoma Breast BRCA 
Yoshihara et 
al., 2015 





Fusion gene Adenocarcinoma Breast BRCA 
Yoshihara et 
al., 2015 
PPP6R3/PREPL PPP6R3 PREPL 11q13.2 2p21 t(2;11)(p21;q13) 
Translocatio
n 
(?) (?) (?) - 
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Fusion gene Adenocarcinoma Breast BRCA 
Yoshihara et 
al., 2015 
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Nacheva et 
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Cervical CESC - 





Fusion gene Adenocarcinoma Breast BRCA 
Yoshihara et 
al., 2015 
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Adenocarcinoma Breast BRCA 
Yoshihara et 
al., 2015 
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Banerji et 
al., 2012 






(?) (?) (?) - 
Table.3 PPP6R3 rearrangements: translocations and fusion genes (reworked from ps://www.ncbi.nlm.nih.gov/homologene; 




PPP6R3 is involved in many and heterogeneous 
genomic translocations in different kind of tumors 
(Table. 3) and it has been proposed that this happens 
because it possess a potent promotor activity (Guo et 
al., 2016). 
Acute lymphoblastic leukemia (ALL) 
Hybrid/Mutated gene 
The fusion gene PPP6R3/ INTS4 has been found in 
T-ALL (Liu et al., 2017), while a t(11;17)(q13;q11) 
PPP6R3/ SSH2 was discovered in a childhood 




The fusion genes PPP6R3/ SHANK2 and PPP6R3/ 
YAP1 have been found in transitional cell carcinoma 
of the bladder (Hu et al., 2018;  
 




Many fusion genes and abnormal translocation was 
discovered. C11orf80 /PPP6R3, KDM2A/PPP6R3, 
PC/PPP6R3, PPP6R3/ FADD, PPP6R3/ MTL5, 
PPP6R3/ POLD3, PPP6R3/ SPTBN2, 
t(11;17)(q13;q11) PPP6R3/SSH2, 
RNF121/PPP6R3, t(11;14)(q13;q12) 
STRN3/PPP6R3 and t(6;11)(p12;q13) 
TNFRSF21/PPP6R3  have been found in breast 
adenocarcinoma (Hu et al., 2018; Yoshihara et al., 
2015; http://www.tumorfusions.org) 










A t(11;15)(q13;q22) RAB11A/PPP6R3 has been 





The fusion gene PPP6R3/ RHOD has been found in 





A t(11;17)(q13;p13)PPP6R3/ USP6 has been found 
in Hairy cell leukemia, Multiple myeloma, and 
Chronic myeloid leukemia (Sawyer et al., 2014 ; 
Sawyer et al., 1995 ; Nacheva et al., 1992; Stopera et 
al., 1990 http://www.tumorfusions.org) 
Hepatocellular carcinoma 
Hybrid/Mutated gene 
A t(11;22)(q13;q12) TMPRSS6/PPP6R3 has been 
found in hepatocellular carcinoma 
(http://www.tumorfusions.org). 
Lung squamous cell carcinoma 
Hybrid/Mutated gene 
In squamous cell carcinoma of the lung was 
discovered the fusion gene EEF1G/PPP6R3 
(Hammerman et al., 2012). Other detected are: a 
t(7;11)(q21;q13) CCDC132/PPP6R3, PPP6R3/ 
ARHGAP1 fusion gene, PPP6R3/ CNTN5 fusion 
gene, PPP6R3/ LRP5 fusion gene, a 
t(7;11)(q13;q34)PPP6R3/ MGAM and a 
t(7;11)(q34;q13) SSBP1/PPP6R3 (Yoshihara et al., 
2015; Hammerman et al., 2012; 
http://www.tumorfusions.org)  
In squamous cell carcinoma of the lung was found 
the presence of the fusion gene 5' EEF1G- 3' PPP6R3 
deriving by the genomic translocation and fusion of 
a part of EEF1G gene with a portion of PPP6R3 
gene, both located on chromosome 11 (Hammerman 
et al., 2012). 
Malignant melanoma 
Hybrid/Mutated gene 
The fusion genes CTTN/PPP6R3, 
NADSYN1/PPP6R3 and PPP6R3/ ACER3 have 
been found in malignant melanoma. In addition, a 
t(1;11)( p36;q13) PPP6R3/ EIF4G3 has also been 
found (Hu et al., 2018; Klijn et al., 2015; 
http://www.tumorfusions.org) 
Malignant Nodular Fasciitis 
Disease 
Nodular fasciitis (NF) occurs in subcutaneous tissue 
and it is generally a benign self-limiting 
myofibroblastic proliferation (Bernstein and Lattes, 
1982). Sometimes was found USP6 gene 
rearrangements (Erickson-Johnson et al., 2011) and 
surprendently in one case was revealed the presence 
of PPP6R3/USP6 fusion gene with both genomic 
amplification and overexpression (Guo et al., 2016) 
that could explain the more aggressive behavior seen 
in malignant NF case report. 
Hybrid/Mutated gene 
It was described the fusion gene 5' PPP6R3 / 3' USP6  
deriving by the genomic translocation and fusion of 
a part of PPP6R3 gene, situated on chromosome 11, 
with a portion of USP6 gene, instead located on 
chromosome 17. In particular, the breakpoint reside 
at the end of exon 1 of PPP6R3 (non-coding) and 155 
bp upstream of coding sequence of USP6 gene (Guo 
et al., 2016). 
Oncogenesis 
The presence of the novel PPP6R3/USP6 fusion 
gene was linked to the increase of malignancy of the 
nodular faciitis (NF). Other tumors were tested for 
the presence of this chimeric gene, such as 
aggressive angiomyxoma , malignant peripheral 
nerve sheath tumor, dermatofibroma/ benign fibrous 
histiocytoma and melanoma. In that cases the results 
were negatives (Guo et al., 2016). Some authors 
detect PPP6R3/USP6 in hairy cell leukemia, 
multiple myeloma and chronic myeloid leukemia 
(Sawyer et al., 2014; Sawyer et al., 1995; Nacheva et 
al., 1992 ; Stopera et al., 1990). 
Nervous system tumors 
Disease 
Malignant peripheral nerve sheath tumors 
(MPNSTs), also called neurofibrosarcomas, are a 
rare aggressive, metastatic, nerve-associated cancer 
type. It was found that in about 10% of this 
malignancy there are mutations on PPP6R3 gene that 
cause disrupt gene transcription (Rahrmann et al., 
2013). In addition a t(8;11)(q21;q13)PPP6R3/ 
ATP6V0D2 is found in sarcoma 
(http://www.tumorfusions.org) and a 
t(11;17)(q13;q11)PPP6R3/SSH2 is detected in 
neuroblastoma (McRobert et al., 1992). 
Ovarian carcinoma 
Disease 
Ovarian malignancies, a type of gynecological 
cancer, show high genomic instability and structural 
chromosomal aberrations which are believed to be 
common mechanisms for both the inactivation of 
tumour suppressor genes and the production of 
fusion genes useful  for cancer vitality. The precise 
roles and functions of these chimeric gene are not 
always understood (Smebye et al., 2017). The fusion 
gene DPP9 /PPP6R3 play a role in tumorigenesis 
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and/or cancer progression through the loss-of-
function of the DPP9 protein, a serine protease that 
act as a tumour suppressor and is a inducer of 
apoptosis. 
Hybrid/Mutated gene 
A fusion gene 5' DPP9 / 3' PPP6R3 deriving from the 
genomic translocation and fusion of a part of DPP9 
(dipeptidyl peptidase 9) gene, situated on 
chromosome 19 with a portion of PPP6R3 gene, 
located on chromosome 11 was found in a high-
grade serous ovarian carcinoma.  
The fusion occured between DPP9 exon 11 and 
PPP6R3 exon 18. DPP9 is a serine protease that act 
as a tumor suppressor and as a inducer of apoptosis 
(Smebye et al., 2017). 
Abnormal protein 
The fusion between DPP9 and PPP6R3 leads to 
disruption and deregulation of expression of DPP9 
gene due to the introduction of a stop codon (TAG) 
directly after the junction that leads to the production 
of truncated form of DPP9 protein.  
This protein loss some functional domains, i.e. the 
peptidase and esterase-lipase domains (Smebye et 
al., 2017) and this causes its loss-of-function. 
Pancreatic cancer 
Hybrid/Mutated gene 
The fusion genes PPP6R3/LRP5 and PPP6R3/ SSH3 
have been found in pancreas adenocarcinoma (Hu et 
al., 2018; http://www.tumorfusions.org) 
Testicular germ cell tumors 
Disease 
Testicular germ cell tumors (TGCTs) are the most 
frequently diagnosed solid malignancies in young 
males and men by 15 to 44 years old and that 
includes two main subtypes: seminomas and non-
seminomas (Hoff et al., 2016; Znaor et al., 2014). 
Some authors found a novel fusion gene 5' PPP6R3 
- 3' DPP3 in pluripotent embryonal carcinomas (EC) 
cell lines (Hoff et al., 2016). 
Hybrid/Mutated gene 
The fusion gene 5' PPP6R3 / 3' DPP3 resulting by 
the translocation t(11;11)(q13;q13) and 
PPP6R3/DPP3 is a novel genomic chimeric 
rearrangement occurs in vitro.  
However more studies are need to characterize it and 
to elucidate its exact role in testicular germ cell 
tumors. 
Abnormal protein 
PPP6R3-DPP3 fusion gene encodes a protein of 198 
amino acids long (Hoff et al., 2016). The functions 
of this chimeric protein are unknown. 
Type 1 diabetes mellitus 4 
The IDDM4 locus has been localized to 
chromosome 11q13 and PPP6R3 gene is linked with 
type 1 diabetes mellitus 4 (Twells et al., 2001). 
Effects on HIV-1 replication 
Knockdown of PPP6R3 by short interfering RNAs 
(siRNA) library screening inhibits HIV-1 replication 
in cultured Jurkat T-cells (Yeung et al., 2009). 
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